The new German Digital Healthcare Act (Digitale‑Versorgung‑Gesetz/DVG), among many other groundbreaking changes, enables any physician or psychotherapist in Germany to prescribe digital health applications (DH-Apps) to the more than 70 million members of the population who are covered by the country’s statutory healthcare system.
Makers of DH-Apps are being given superfast access to the highly lucrative German healthcare reimbursement system. Most notably, for a period of up to 12 months they have the chance to additionally test their products and gather real-world scientific data on their benefits. The German statutory health insurance funds will also be required to fully reimburse the sales price of DH-Apps already during their testing & development, which their makers may freely set at the start.
This legislation massively pushes Germany towards Healthcare 4.0 and may usher in an era of great opportunities: not only for traditional players in the life sciences and healthcare market, but also for newcomers to this sector, including tech giants, tech startups and data-driven enterprises.